Literature DB >> 6259972

Use of a continuous feline cell line for virologic and serologic investigations of bovine leukemia virus infections.

M J Van der Maaten, J M Miller.   

Abstract

Simple, practical, reproductible methods for the detection of bovine leukemia virus (BLV) in peripheral blood leukocytes and BLV-neutralizing antibodies in bovine sera are described. Virus detection is based on syncytium formation in transformed feline (F-81) cells. The use of multiwell culture plates provides practical benefits in testing large numbers of samples. Results obtained in 2 farm herds show that the agreement of serologic and virologic test results may vary considerably from herd to herd.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6259972

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN： 0002-9645            Impact factor:   1.156


  5 in total

1.  Intestinal Shiga toxin-producing Escherichia coli bacteria mitigate bovine leukemia virus infection in experimentally infected sheep.

Authors:  Witold A Ferens; Rowland Cobbold; Carolyn J Hovde
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Peripheral blood mononuclear cells from sheep infected with a variant of bovine leukemia virus synthesize envelope glycoproteins but fail to induce syncytia in culture.

Authors:  E R Johnston; M A Powers; L C Kidd; K Radke
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

3.  Levamisole does not affect the virological and serological responses of bovine leukemia virus-infected cattle and sheep.

Authors:  M J Van der Maaten; M J Schmerr; J M Miller; J M Sacks
Journal:  Can J Comp Med       Date:  1983-10

4.  The role of virus dose in experimental bovine leukemia virus infection in sheep.

Authors:  T Stirtzinger; V E Valli; J M Miller
Journal:  Can J Vet Res       Date:  1988-04       Impact factor: 1.310

5.  A strategy for control of bovine leukemia virus infection: test and corrective management.

Authors:  R Ruppanner; D E Behymer; S Paul; J M Miller; G H Theilen
Journal:  Can Vet J       Date:  1983-06       Impact factor: 1.008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.